Evidence map›Paper›PMID 30827922›Full record

ArticleNeuroImage. Clinical

Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI.

Rogier A Feis, Mark J R J Bouts, Jessica L Panman, Lize C Jiskoot, Elise G P Dopper, Tijn M Schouten, Frank de Vos, Jeroen van der Grond, John C van Swieten, Serge A R B Rombouts

Abstract readPublished Erratum
In one paragraph

Article in NeuroImage. Clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Rogier A FeisDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, Netherlands. Electronic address: r.a.feis@lumc.nl.
Mark J R J BoutsDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, Netherlands; Institute of Psychology, Leiden University, Leiden, Netherlands. Electronic address: m.j.r.j.bouts@fsw.leidenuniv.nl.
Jessica L PanmanDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands. Electronic address: j.panman@erasmusmc.nl.
Lize C JiskootDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands. Electronic address: l.c.jiskoot@erasmusmc.nl.
Elise G P DopperDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands; Alzheimer Centre & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, Netherlands. Electronic address: e.dopper@erasmusmc.nl.
Tijn M SchoutenDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, Netherlands; Institute of Psychology, Leiden University, Leiden, Netherlands. Electronic address: t.m.schouten@fsw.leidenuniv.nl.
Frank de VosDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, Netherlands; Institute of Psychology, Leiden University, Leiden, Netherlands. Electronic address: f.de.vos@fsw.leidenuniv.nl.
Jeroen van der GrondDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands. Electronic address: j.van_der_grond@lumc.nl.
John C van SwietenDepartment of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands; Department of Clinical Genetics, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, Netherlands. Electronic address: j.c.vanswieten@erasmusmc.nl.
Serge A R B RomboutsDepartment of Radiology, Leiden University Medical Centre, Leiden, Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, Netherlands; Institute of Psychology, Leiden University, Leiden, Netherlands. Electronic address: s.a.r.b.rombouts@lumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClassification models based on magnetic resonance imaging (MRI) may aid early diagnosis of frontotemporal dementia (FTD) but have only been applied in established FTD cases. Detection of FTD patients in earlier disease stages, such as presymptomatic mutation carriers, may further advance early diagnosis and treatment. In this study, we aim to distinguish presymptomatic FTD mutation carriers from controls on an individual level using multimodal MRI-based classification.

methodsAnatomical MRI, diffusion tensor imaging (DTI) and resting-state functional MRI data were collected in 55 presymptomatic FTD mutation carriers (8 microtubule-associated protein Tau, 35 progranulin, and 12 chromosome 9 open reading frame 72) and 48 familial controls. We calculated grey and white matter density features from anatomical MRI scans, diffusivity features from DTI, and functional connectivity features from resting-state functional MRI. These features were applied in a recently introduced multimodal behavioural variant FTD (bvFTD) classification model, and were subsequently used to train and test unimodal and multimodal carrier-control models. Classification performance was quantified using area under the receiver operator characteristic curves (AUC).

resultsThe bvFTD model was not able to separate presymptomatic carriers from controls beyond chance level (AUC = 0.582, p = 0.078). In contrast, one unimodal and several multimodal carrier-control models performed significantly better than chance level. The unimodal model included the radial diffusivity feature and had an AUC of 0.642 (p = 0.032). The best multimodal model combined radial diffusivity and white matter density features (AUC = 0.684, p = 0.004).

conclusionsFTD mutation carriers can be separated from controls with a modest AUC even before symptom-onset, using a newly created carrier-control classification model, while this was not possible using a recent bvFTD classification model. A multimodal MRI-based classification score may therefore be a useful biomarker to aid earlier FTD diagnosis. The exclusive selection of white matter features in the best performing model suggests that the earliest FTD-related pathological processes occur in white matter.

Indexed as

C9orf72 humanclassificationDiffusion Tensor ImagingFrontotemporal dementiaGRN protein humanmachine learningMAPT protein humanMultimodal MRIResting-state functional MRI

Identifiers

PMID30827922
PMCPMC6543025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.